Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 myocardial protection system that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products that are used in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measures the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers, as well as other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ATRI
Previous Symbol
CUSIP04990410
Phone972-390-9800
Debt
Debt-to-Equity RatioN/A
Current Ratio10.10
Quick Ratio7.42
Price-To-Earnings
Trailing P/E Ratio41.31
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$146.60 million
Price / Sales9.65
Cash Flow$22.7550 per share
Price / Cash Flow33.59
Book Value$99.57 per share
Price / Book7.68
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$36.59 million
Net Margins23.19%
Return on Equity18.01%
Return on Assets16.26%
Miscellaneous
Employees528
Outstanding Shares1,850,000
Market Cap$1.44 billion
OptionableNot Optionable
Atrion (NASDAQ:ATRI) Frequently Asked Questions
What is Atrion's stock symbol?
Atrion trades on the NASDAQ under the ticker symbol "ATRI."
How often does Atrion pay dividends? What is the dividend yield for Atrion?
Atrion announced a quarterly dividend on Monday, November 12th. Stockholders of record on Monday, December 3rd will be given a dividend of $1.35 per share on Monday, December 17th. This represents a $5.40 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Friday, November 30th. View Atrion's Dividend History.
How were Atrion's earnings last quarter?
Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings results on Friday, November, 9th. The medical instruments supplier reported $4.96 EPS for the quarter. The medical instruments supplier earned $39.27 million during the quarter. Atrion had a return on equity of 18.01% and a net margin of 23.19%. View Atrion's Earnings History.
When is Atrion's next earnings date?
Has Atrion been receiving favorable news coverage?
News headlines about ATRI stock have been trending positive this week, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Atrion earned a news impact score of 2.6 on InfoTrie's scale. They also gave news coverage about the medical instruments supplier a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the company's share price in the near future.
Who are some of Atrion's key competitors?
Some companies that are related to Atrion include Haemonetics (HAE), Insulet (PODD), ICU Medical (ICUI), Penumbra (PEN), Globus Medical (GMED), Integra Lifesciences (IART), Cantel Medical (CMD), Merit Medical Systems (MMSI), Novocure (NVCR), NuVasive (NUVA), Glaukos (GKOS), Tandem Diabetes Care (TNDM), Irhythm Technologies (IRTC), Mazor Robotics (MZOR) and Luminex (LMNX).
Who are Atrion's key executives?
Atrion's management team includes the folowing people:
- Mr. Emile A. Battat, Exec. Chairman (Age 80)
- Mr. David A. Battat, Pres & CEO (Age 48)
- Mr. Jeffery Strickland, VP, CFO, Sec. & Treasurer (Age 59)
Who are Atrion's major shareholders?
Atrion's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Neuberger Berman Group LLC (7.31%), BlackRock Inc. (5.27%), Vanguard Group Inc. (4.55%), Renaissance Technologies LLC (3.69%), Cornerstone Wealth Management LLC (3.57%) and Thomson Horstmann & Bryant Inc. (0.79%). Company insiders that own Atrion stock include Emile A Battat and Jeffery Strickland. View Institutional Ownership Trends for Atrion.
Which institutional investors are selling Atrion stock?
ATRI stock was sold by a variety of institutional investors in the last quarter, including DF Dent & Co. Inc., Wells Fargo & Company MN, BlackRock Inc., JPMorgan Chase & Co., Renaissance Technologies LLC, BTIM Corp., Citadel Advisors LLC and Credit Suisse AG. View Insider Buying and Selling for Atrion.
Which institutional investors are buying Atrion stock?
ATRI stock was acquired by a variety of institutional investors in the last quarter, including Cornerstone Wealth Management LLC, Morgan Stanley, Neuberger Berman Group LLC, Assenagon Asset Management S.A., First Trust Advisors LP, SG Americas Securities LLC, Denali Advisors LLC and Rhumbline Advisers. View Insider Buying and Selling for Atrion.
How do I buy shares of Atrion?
Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Atrion's stock price today?
One share of ATRI stock can currently be purchased for approximately $764.34.
How big of a company is Atrion?
Atrion has a market capitalization of $1.44 billion and generates $146.60 million in revenue each year. Atrion employs 528 workers across the globe.
What is Atrion's official website?
How can I contact Atrion?
Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected]
MarketBeat Community Rating for Atrion (NASDAQ ATRI)
MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days.
